ALZHEIMER DEMENTIA
Clinical trials for ALZHEIMER DEMENTIA explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER DEMENTIA trials appear
Sign up with your email to follow new studies for ALZHEIMER DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a lower dose of Alzheimer's drug work just as well?
Disease control Not yet recruitingThis study will test whether a lower dose of the drug lecanemab works as well as the standard dose for people with early Alzheimer's disease. Researchers will compare brain scans, memory tests, and blood markers in 140 participants over 18 months. The goal is to find the most eff…
Matched conditions: ALZHEIMER DEMENTIA
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New study aims to pinpoint which Alzheimer's patients respond best to antibody drug
Disease control Not yet recruitingThis study will test the antibody drug lecanemab in 120 people with mild cognitive impairment or mild-to-moderate Alzheimer's disease. Using PET scans to measure amyloid and tau proteins in the brain, researchers hope to identify which patients are most likely to benefit from tre…
Matched conditions: ALZHEIMER DEMENTIA
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 26, 2026 13:15 UTC